198 related articles for article (PubMed ID: 8921957)
1. Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B, and C.
Toyosaki T; Yoshioka T; Tsuruta Y; Yutsudo T; Iwasaki M; Suzuki R
Eur J Immunol; 1996 Nov; 26(11):2693-701. PubMed ID: 8921957
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins).
Braun MA; Gerlach D; Hartwig UF; Ozegowski JH; Romagné F; Carrel S; Köhler W; Fleischer B
J Immunol; 1993 Mar; 150(6):2457-66. PubMed ID: 8450222
[TBL] [Abstract][Full Text] [Related]
3. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B.
Abe J; Forrester J; Nakahara T; Lafferty JA; Kotzin BL; Leung DY
J Immunol; 1991 Jun; 146(11):3747-50. PubMed ID: 1903412
[TBL] [Abstract][Full Text] [Related]
4. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells.
Imanishi K; Igarashi H; Uchiyama T
J Immunol; 1990 Nov; 145(10):3170-6. PubMed ID: 2230113
[TBL] [Abstract][Full Text] [Related]
5. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
Norrby-Teglund A; Nepom GT; Kotb M
Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens.
Brouillard JN; Günther S; Varma AK; Gryski I; Herfst CA; Rahman AK; Leung DY; Schlievert PM; Madrenas J; Sundberg EJ; McCormick JK
J Mol Biol; 2007 Apr; 367(4):925-34. PubMed ID: 17303163
[TBL] [Abstract][Full Text] [Related]
7. Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein.
Watanabe-Ohnishi R; Aelion J; LeGros L; Tomai MA; Sokurenko EV; Newton D; Takahara J; Irino S; Rashed S; Kotb M
J Immunol; 1994 Feb; 152(4):2066-73. PubMed ID: 8120408
[TBL] [Abstract][Full Text] [Related]
8. Isolation of a new superantigen with potent mitogenic activity to murine T cells from Streptococcus pyogenes.
Nemoto E; Rikiishi H; Sugawara S; Okamoto S; Tamura K; Maruyama Y; Kumagai K
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):81-91. PubMed ID: 8880132
[TBL] [Abstract][Full Text] [Related]
9. Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes.
Rikiishi H; Okamoto S; Sugawara S; Tamura K; Liu ZX; Kumagai K
Immunology; 1997 Jul; 91(3):406-13. PubMed ID: 9301530
[TBL] [Abstract][Full Text] [Related]
10. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
Ito Y; Abe J; Yoshino K; Takeda T; Kohsaka T
J Immunol; 1995 Jun; 154(11):5896-906. PubMed ID: 7751634
[TBL] [Abstract][Full Text] [Related]
11. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
12. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.
Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H
Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143
[TBL] [Abstract][Full Text] [Related]
13. Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes.
Proft T; Arcus VL; Handley V; Baker EN; Fraser JD
J Immunol; 2001 Jun; 166(11):6711-9. PubMed ID: 11359827
[TBL] [Abstract][Full Text] [Related]
14. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
15. Clonal heterogeneity of superantigen reactivity in human V beta 6+ T cell clones. Limited contributions of V beta sequence polymorphisms.
Goronzy JJ; Oppitz U; Weyand CM
J Immunol; 1992 Jan; 148(2):604-11. PubMed ID: 1530864
[TBL] [Abstract][Full Text] [Related]
16. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms.
Uchiyama T; Miyoshi-Akiyama T; Kato H; Fujimaki W; Imanishi K; Yan XJ
J Immunol; 1993 Oct; 151(8):4407-13. PubMed ID: 8409410
[TBL] [Abstract][Full Text] [Related]
17. The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action.
Li PL; Tiedemann RE; Moffat SL; Fraser JD
J Exp Med; 1997 Aug; 186(3):375-83. PubMed ID: 9236189
[TBL] [Abstract][Full Text] [Related]
18. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).
Norrby-Teglund A; Newton D; Kotb M; Holm SE; Norgren M
Infect Immun; 1994 Dec; 62(12):5227-33. PubMed ID: 7960098
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Collins CM; Gutman DM; Kline JB; O'Brien SM; Tranter HS; Acharya KR
EMBO J; 1999 Jan; 18(1):9-21. PubMed ID: 9878045
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
